PARPi maintenance: A new paradigm in the management of frontline ovarian cancer (ID 1784)
What’s new in metastatic pancreatic cancer management? (ID 1785)
Recent advances in metastatic prostate cancer management (ID 1881)
Expert Opinion on ‘PARP inhibitors as targeted therapy for personalized medicine’ - Panel Discussion (ID 1882)